XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1

NET SALES (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

SCHEDULE OF NET SALES BY MARKET

The following tables summarize our net sales by market for the three months ended March 31, 2025 and 2024, respectively:

 SCHEDULE OF NET SALES BY MARKET

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Three Months Ended March 31, 2025
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device		$	5,772			$	1,730			$	568			$	8,070
Medical Imaging			6,708				1,873				7				8,588
Industrial			4,706				2,132				107				6,945
Aerospace and Defense			2,782				478				32				3,292
Total net sales		$	19,968			$	6,213			$	714			$	26,895

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Three Months Ended March 31, 2024
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device(2)		$	7,167			$	2,777			$	794			$	10,738
Medical Imaging(2)			7,073				2,468				3				9,544
Industrial			5,429				2,347				297				8,073
Aerospace and Defense			5,545				242				73				5,860
Total net sales		$	25,214			$	7,834			$	1,167			$	34,215

1	Noncash consideration represents material provided by the customer used in the build of the product.
2	Medical, as reported in the prior year period filing, has been split between Medical Device and Medical Imaging to conform with the current year presentation.

SCHEDULE OF CONTRACT ASSETS

Contract assets, recorded as such in the condensed consolidated balance sheet, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the three months ended March 31, 2025 were as follows:

 SCHEDULE OF CONTRACT ASSETS

Balances as of January 1, 2025		$	13,792
Increase (decrease) attributed to:
Amounts transferred over time to contract assets			19,968
Allowance for current expected credit losses			-
Amounts invoiced during the period			(20,356	)
Balance outstanding as of March 31, 2025		$	13,404

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration